{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:52:31Z","timestamp":1789667551620,"version":"4.0.1"},"publisher-location":"Dordrecht","reference-count":111,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789402410778","type":"print"},{"value":"9789402410792","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-94-024-1079-2_32","type":"book-chapter","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T04:54:12Z","timestamp":1503896052000},"page":"371-400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Investigation of the Role of a Supplementation with Taurine on the Effects of Hypoglycemic-Hypotensive Therapy Against Diabetes-Induced Nephrotoxicity in Rats"],"prefix":"10.1007","author":[{"given":"Kashyap","family":"Pandya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar A.","family":"Lau-Cam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"32_CR1","first-page":"293","volume":"1","author":"W Abebe","year":"2011","unstructured":"Abebe W, Mozaffarin MS (2011) Role of taurine in the vasculature: an overview of experimental and human studies. Am J Cardiovasc Dis 1:293\u2013311","journal-title":"Am J Cardiovasc Dis"},{"key":"32_CR2","first-page":"119","volume":"776","author":"M Acharya","year":"2013","unstructured":"Acharya M, Lau-Cam CA (2013) Comparative evaluation of the effects of taurine and thiotaurine on alterations of the cellular redox status and activities of antioxidant and glutathione-related enzymes by acetaminophen in the rat. Adv Exp Med Biol 776:119\u2013215","journal-title":"Adv Exp Med Biol"},{"key":"32_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","volume":"63","author":"AI Adler","year":"2003","unstructured":"Adler AI, Stevens RJ, Manley SE et al (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63:225\u2013232","journal-title":"Kidney Int"},{"key":"32_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121\u2013126","journal-title":"Methods Enzymol"},{"key":"32_CR5","first-page":"64","volume":"11","author":"H Ahmadvand","year":"2012","unstructured":"Ahmadvand H (2012) Effects of coenzyme Q10 on hemoglobin A1c, serum urea and creatinine in alloxan-induced type 1 diabetic rats. Iran J Pharmacol Ther 11:64\u201367","journal-title":"Iran J Pharmacol Ther"},{"key":"32_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1470320312460881","volume":"12","author":"DH Akbar","year":"2013","unstructured":"Akbar DH, Hagras MM, Amin HS, Khorshid OA (2013) Comparison between the effect of glibenclamide and captopril on experimentally induced diabetic nephropathy in rats. J Renin Angiotensin Adosterone Syst 12:103\u2013115","journal-title":"J Renin Angiotensin Adosterone Syst"},{"key":"32_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cbi.2011.03.014","volume":"192","author":"AA Alhaider","year":"2011","unstructured":"Alhaider AA, Korashy HM, Sayed-Ahmed MM et al (2011) Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression. Chem Biol Interact 192:233\u2013242","journal-title":"Chem Biol Interact"},{"key":"32_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jnutbio.2005.06.007","volume":"16","author":"DA Allen","year":"2005","unstructured":"Allen DA, Yaqoob MH, Harwood SM (2005) Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J Nutr Biochem 16:705\u2013713","journal-title":"J Nutr Biochem"},{"issue":"Suppl. 1","key":"32_CR9","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc14-S014","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association (2014) Standards of medical care in diabetes-2014. Diabetes Care 37(Suppl. 1):S14\u2013S80","journal-title":"Diabetes Care"},{"key":"32_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3923\/pjbs.2011.219.225","volume":"14","author":"P Anand","year":"2011","unstructured":"Anand P, Rajakumar D, Jeraud M, Felix AJ, Balasubramanian T (2011) Effects of taurine on glutathione peroxidase, glutathione reductase and reduced glutathione levels in rats. Pak J Biol Sci 14:219\u2013225","journal-title":"Pak J Biol Sci"},{"key":"32_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1440-1681.2004.03982.x","volume":"31","author":"M Anjaneyulu","year":"2004","unstructured":"Anjaneyulu M, Chopra K (2004) Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 31:244\u2013248","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"32_CR12","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1111\/j.1523-1755.2005.00287.x","volume":"67","author":"K Asaba","year":"2005","unstructured":"Asaba K, Tojo A, Onozato ML et al (2005) Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 67:1890\u20131898","journal-title":"Kidney Int"},{"key":"32_CR13","doi-asserted-by":"publisher","first-page":"819310","DOI":"10.1155\/2012\/819310","volume":"2012","author":"SM Bandeira","year":"2012","unstructured":"Bandeira SM, Guedes GS, da Fonseca LJ et al (2012) Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity. Oxid Med Cell Longev 2012:819310","journal-title":"Oxid Med Cell Longev"},{"key":"32_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/1056-8727(94)90040-X","volume":"8","author":"DJ Barnes","year":"1994","unstructured":"Barnes DJ, Viberti GC (1994) Strategies for the prevention of diabetic kidney disease: early antihypertensive treatment or improved glycemic control? J Diabetes Complicat 8:189\u20131921","journal-title":"J Diabetes Complicat"},{"key":"32_CR15","unstructured":"Ba\u015ftar I, Se\u00e7kin S, Uysal N, Ayka\u00e7-Toker G (1998) Effect of streptozotocin on glutathione and lipid peroxide levels in various tissues of rats. Res Commun Mol Pathol Pharmacol 102:265\u2013272"},{"key":"32_CR16","first-page":"1714","volume":"31","author":"P Bernadet-Monrozies","year":"2002","unstructured":"Bernadet-Monrozies P, Rostaing L, Kamar N, Durand D (2002) The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure. Presse Med 31:1714\u20131720","journal-title":"Presse Med"},{"key":"32_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.phrs.2009.05.006","volume":"60","author":"TM Bhavasar","year":"2009","unstructured":"Bhavasar TM, Cantor JO, Patel SN, Lau-Cam CA (2009) Attenuating effect of taurine on lipopolysaccharide-induced acute lung injury in hamsters. Pharmacol Res 60:418\u2013428","journal-title":"Pharmacol Res"},{"key":"32_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0940-2993(11)80045-X","volume":"46","author":"H Br\u00e4unlich","year":"1994","unstructured":"Br\u00e4unlich H, Marx F, Stein G (1994) Glutathione status, lipid peroxidation and kidney function in streptozotocin diabetic rats. Exp Toxicol Pathol 46:143\u2013147","journal-title":"Exp Toxicol Pathol"},{"key":"32_CR19","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/sj.ejcn.1601955","volume":"58","author":"C Br\u00f8ns","year":"2004","unstructured":"Br\u00f8ns C, Spohr C, Storgaard H et al (2004) Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. Eur J Clin Nutr 58:1239\u20131247","journal-title":"Eur J Clin Nutr"},{"key":"32_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0076-6879(78)52032-6","volume":"52","author":"JA Buege","year":"1978","unstructured":"Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302\u2013310","journal-title":"Methods Enzymol"},{"key":"32_CR21","doi-asserted-by":"crossref","unstructured":"Butt S, Hall P, Nurko S (2010) Diabetic nephropathy. Cleveland Clinic Foundation, Center for Continuing Education, Lyndhurst, OH","DOI":"10.1016\/B978-1-4160-6643-9.00128-4"},{"key":"32_CR22","doi-asserted-by":"crossref","unstructured":"Chang J-M, Kuo M-C, Kuo H-T, Chiu Y-W, Chen H-C (2005) Increased glomerular and extracellular malondialdehyde levels in patients an rats with diabetic nephropathy. J Lab Clin Med 146:210\u2013215","DOI":"10.1016\/j.lab.2005.05.007"},{"key":"32_CR23","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/jnr.10027","volume":"66","author":"WQ Chen","year":"2001","unstructured":"Chen WQ, Jin H, Nguyen M et al (2001) Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons. J Neurosci Res 66:612\u2013619","journal-title":"J Neurosci Res"},{"key":"32_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4239\/wjd.v1.i2.48","volume":"1","author":"PK Dabla","year":"2010","unstructured":"Dabla PK (2010) Renal function in diabetic nephropathy. World J Diabetes 1:48\u201356","journal-title":"World J Diabetes"},{"key":"32_CR25","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00726-012-1225-y","volume":"43","author":"J Das","year":"2012","unstructured":"Das J, Sil PC (2012) Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats. Amino Acids 43:1509\u20131533","journal-title":"Amino Acids"},{"key":"32_CR26","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00726-011-0904-4","volume":"42","author":"J Das","year":"2012","unstructured":"Das J, Ghosh J, Manna P, Sil PC (2012) Taurine protects rat testes against doxorubicin-induced oxidative stress as well as p53, Fas and caspase 12-mediated apoptosis. Amino Acids 42:1839\u20131855","journal-title":"Amino Acids"},{"key":"32_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0002-9343(96)00353-1","volume":"102","author":"MB Davidson","year":"1997","unstructured":"Davidson MB, Peters AL (1997) An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med 102:99\u2013110","journal-title":"Am J Med"},{"key":"32_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1056\/NEJM199508313330902","volume":"333","author":"RA DeFronzo","year":"1995","unstructured":"DeFronzo RA, Goodman AM (1995) Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 333:541\u2013549","journal-title":"N Engl J Med"},{"key":"32_CR29","first-page":"1568","volume":"81","author":"M Dorella","year":"1996","unstructured":"Dorella M, Giusto M, Da Tos V et al (1996) Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance. J Clin Endocrinol Metab 81:1568\u20131564","journal-title":"J Clin Endocrinol Metab"},{"key":"32_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2165\/00126839-200405040-00003","volume":"5","author":"E Elmali","year":"2004","unstructured":"Elmali E, Altan N, Bukan N (2004) Effect of the sulphonylurea glibenclamide on liver and kidney antioxidant enzymes in streptozotocin-induced diabetic rats. Drugs R D 5:203\u2013208","journal-title":"Drugs R D"},{"key":"32_CR31","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/ijms12010829","volume":"12","author":"OO Erejuwa","year":"2011","unstructured":"Erejuwa OO, Sulaiman SA, Ab Wahab MS et al (2011) Comparison of antioxidant effects of honey, glibenclamide, metformin, and their combinations in the kidneys of streptozotocin-induced diabetic rats. Int J Mol Sci 12:829\u2013843","journal-title":"Int J Mol Sci"},{"key":"32_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1210\/er.2001-0039","volume":"23","author":"JL Evans","year":"2002","unstructured":"Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599\u2013622","journal-title":"Endocr Rev"},{"key":"32_CR33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0076-6879(84)05015-1","volume":"105","author":"L Floh\u00e9","year":"1984","unstructured":"Floh\u00e9 L, G\u00fcnzler WA (1984) Assay of glutathione peroxidase. Methods Enzymol 105:114\u2013120","journal-title":"Methods Enzymol"},{"key":"32_CR34","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.2337\/db08-0057","volume":"57","author":"JM Forbes","year":"2008","unstructured":"Forbes JM, Coughlan MT, Cooper ME (2008) Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57:1446\u20131454","journal-title":"Diabetes"},{"key":"32_CR35","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1172\/JCI40671","volume":"120","author":"M Fortes","year":"2010","unstructured":"Fortes M, Herbart S, Lecher J et al (2010) Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state. J Clin Invest 120:2355\u20132369","journal-title":"J Clin Invest"},{"issue":"Focus Issue","key":"32_CR36","first-page":"54","volume":"18","author":"A Gajdo\u0161ik","year":"1999","unstructured":"Gajdo\u0161ik A, Gajdo\u0161ikov\u00e1 A, \u0160tefek M, Navarov\u00e1 J, Hozov\u00e1 R (1999) Streptozotocin-induced experimental diabetes in male Wistar rats. Gen Physiol Biophys 18(Focus Issue):54\u201362","journal-title":"Gen Physiol Biophys"},{"key":"32_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s10517-008-0258-4","volume":"146","author":"LK Gavrovskaya","year":"2008","unstructured":"Gavrovskaya LK, Ryzhova OV, Safonova AF et al (2008) Protective effect of taurine on rats with experimental insulin-dependent diabetes mellitus. Bull Exp Biol Med 146:226\u2013228","journal-title":"Bull Exp Biol Med"},{"key":"32_CR38","first-page":"691","volume":"6","author":"H Genc","year":"2010","unstructured":"Genc H, Karadurmus N, Kisa U et al (2010) Transforming growth factor \u03b2 (TGF-\u03b2) levels in otherwise healthy subjects with impaired glucose tolerance. Endrokrynol Pol 6:691\u2013694","journal-title":"Endrokrynol Pol"},{"key":"32_CR39","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2337\/diabetes.47.3.414","volume":"47","author":"RE Gilbert","year":"1998","unstructured":"Gilbert RE, Cox A, Wu LL et al (1998) Expression of transforming growth factor-\u03b21 and type IV collagen in the renal tubulointerstitium on experimental diabetes: effects of ACE inhibition. Diabetes 47:414\u2013422","journal-title":"Diabetes"},{"key":"32_CR40","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1210\/jc.2007-1817","volume":"93","author":"SY Goh","year":"2008","unstructured":"Goh SY, Cooper ME (2008) The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93:1143\u20131152","journal-title":"J Clin Endocrinol Metab"},{"key":"32_CR41","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/BF00626360","volume":"41","author":"L Gonz\u00e1lez-Sicilia de Llamas","year":"1991","unstructured":"Gonz\u00e1lez-Sicilia de Llamas L, Garcia Alberola A, Lopez-Herrera ML et al (1991) Effects of captopril on diabetic nephropathy in hypertensive women. Eur J Clin Pharmacol 41:405\u2013409","journal-title":"Eur J Clin Pharmacol"},{"key":"32_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0885-4505(90)90002-I","volume":"43","author":"HO Goodman","year":"1990","unstructured":"Goodman HO, Shihabi ZK (1990) Supplemental taurine in diabetic rats: effects on plasma glucose and triglycerides. Biochem Med Metab Biol 43:1\u20139","journal-title":"Biochem Med Metab Biol"},{"key":"32_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0003-2697(66)90025-X","volume":"15","author":"H G\u00fcntherberg","year":"1966","unstructured":"G\u00fcntherberg H, Rost J (1966) The true oxidized glutathione content of red blood cells obtained by new enzymic and paper chromatographic methods. Anal Biochem 15:205\u2013210","journal-title":"Anal Biochem"},{"key":"32_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4103\/0973-3930.70865","volume":"30","author":"RK Gupta","year":"2010","unstructured":"Gupta RK, Rehan HS, Rohatagi A et al (2010) The effectof glizipide, metformin and rosiglitazone on nontraditional cardiovascular risk factors in newly diagnosed patients with type 2 diabetes mellitus. Int J Diab Dev Ctries 30:123\u2013128","journal-title":"Int J Diab Dev Ctries"},{"key":"32_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1440-1681.2006.04345.x","volume":"33","author":"HH Hagar","year":"2006","unstructured":"Hagar HH, El Etter E, Arafa M (2006) Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats. Clin Exp Pharmacol Physiol 33:189\u2013196","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"32_CR46","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.2337\/diabetes.53.9.2455","volume":"53","author":"T Hamanishi","year":"2004","unstructured":"Hamanishi T, Furuta H, Kato H et al (2004) Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patient. Diabetes 53:2455\u20132460","journal-title":"Diabetes"},{"key":"32_CR47","first-page":"E35","volume":"54","author":"S Higo","year":"2008","unstructured":"Higo S, Miyata S, Jiang QY et al (2008) Taurine administration after appearance of proteinuria retards progression of diabetic nephropathy in rats. Kobe J Med Sci 54:E35\u2013E45","journal-title":"Kobe J Med Sci"},{"key":"32_CR48","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/0003-2697(76)90326-2","volume":"74","author":"PJ Hissin","year":"1976","unstructured":"Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74:214\u2013226","journal-title":"Anal Biochem"},{"key":"32_CR49","doi-asserted-by":"publisher","first-page":"846","DOI":"10.2337\/diabetes.52.3.846","volume":"52","author":"AD Hodgkinson","year":"2003","unstructured":"Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG (2003) The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes 52:846\u2013851","journal-title":"Diabetes"},{"key":"32_CR50","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00726-011-0883-5","volume":"42","author":"T Ito","year":"2012","unstructured":"Ito T, Schaffer SW, Azuma J (2012) The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 42:1529\u20131539","journal-title":"Amino Acids"},{"key":"32_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0168-8227(96)01258-2","volume":"33","author":"M Jasik","year":"1996","unstructured":"Jasik M, Kasperska-Dworak A, Czyzyk A (1996) Effect of nifedipine, captopril and prazosin on secretory function of pancreatic \u03b2-cells in hypertensive patients with type-2 (non-insuln-dependent) diabetes and in hypertensive non-diabetics. Diabetes Res Clin Pract 33:59\u201366","journal-title":"Diabetes Res Clin Pract"},{"key":"32_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13105-013-0275-2","volume":"70","author":"EB Kalaz","year":"2013","unstructured":"Kalaz EB, \u00c7oban J, Ayd\u0131n AF et al (2013) Carnosine and taurine treatments decreased oxidative stress and tissue damage induced by D-galactose in rat live. J Physiol Biochem 70:15\u201325","journal-title":"J Physiol Biochem"},{"key":"32_CR53","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0014-2999(00)00320-4","volume":"398","author":"M Katoh","year":"2000","unstructured":"Katoh M, Ohmachi Y, Kurosawa Y et al (2000) Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice. Eur J Pharmacol 398:381\u2013387","journal-title":"Eur J Pharmacol"},{"key":"32_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0009-8981(99)00115-1","volume":"287","author":"K K\u0119dziora-Kornatowska","year":"1999","unstructured":"K\u0119dziora-Kornatowska K (1999) Effect of angiotensin convertase inhibitors and AT1 angiotensin receptor antagonists on the development of oxidative stress in the kidney of diabetic rats. Clin Chim Acta 287:19\u201327","journal-title":"Clin Chim Acta"},{"key":"32_CR55","doi-asserted-by":"crossref","unstructured":"K\u0119dziora-Kornatowska KZ, Luciak M, Paszkowski J (2000) Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors. IUBMB Life 49:303\u2013307","DOI":"10.1080\/15216540050033177"},{"key":"32_CR56","first-page":"210821","volume":"2012","author":"J Kim","year":"2012","unstructured":"Kim J, Shon E, Kim C-S, Kim JS (2012) Renal podocyte injury in a rat model of type 2 diabetes is prevented by metformin. Exp Diabetes Res 2012:210821","journal-title":"Exp Diabetes Res"},{"key":"32_CR57","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1365-2125.1999.00092.x","volume":"48","author":"P King","year":"1999","unstructured":"King P, Peacock I, Donnelly R (1999) The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol 48:643\u2013648","journal-title":"Br J Clin Pharmacol"},{"key":"32_CR58","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.2337\/diacare.13.11.1109","volume":"13","author":"J Kodama","year":"1990","unstructured":"Kodama J, Katayama S, Tanaka K et al (1990) Effect of captopril on glucose concentration: possible role of augmentated postprandial forearm blood flow. Diabetes Care 13:1109\u20131111","journal-title":"Diabetes Care"},{"key":"32_CR59","doi-asserted-by":"publisher","first-page":"397307","DOI":"10.1155\/2014\/397307","volume":"2014","author":"JH Koh","year":"2014","unstructured":"Koh JH, Lee ES, Hyun M et al (2014) Taurine alleviates the progression of diabetic nephropathy in type 2 diabetic rat model. Int J Endocrinol 2014:397307","journal-title":"Int J Endocrinol"},{"issue":"Suppl 1","key":"32_CR60","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1423-0127-17-S1-S11","volume":"17","author":"WJ L\u2019Amoreaux","year":"2010","unstructured":"L\u2019Amoreaux WJ, Cuttitta C, Santora A, Blaize JF et al (2010) Taurine regulates insulin release from pancreatic beta cell lines. J Biomed Sci 17(Suppl 1):S11","journal-title":"J Biomed Sci"},{"key":"32_CR61","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4899-0117-0_13","volume":"442","author":"E Lim","year":"1998","unstructured":"Lim E, Park S, Kim H (1998) Effect of taurine supplementation on the lipid peroxide formation and the activities of glutathione-related enzymes in the liver and islet of type I and II diabetic model mice. Adv Exp Med Biol 442:99\u2013103","journal-title":"Adv Exp Med Biol"},{"key":"32_CR62","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cbi.2007.11.012","volume":"173","author":"Z Liu","year":"2008","unstructured":"Liu Z, Li J, Zeng Z et al (2008) The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozotocin-induced diabetic rats. Chem Biol Interact 173:68\u201375","journal-title":"Chem Biol Interact"},{"key":"32_CR63","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0014-2999(98)00807-3","volume":"364","author":"R Lupi","year":"1999","unstructured":"Lupi R, Del Guerra S, Tellini C et al (1999) The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose. Eur J Pharmacol 364:205\u2013209","journal-title":"Eur J Pharmacol"},{"key":"32_CR64","unstructured":"Misra HP (1985) Adrenochrome assay. In: Greenwald RA (ed) CRC handbook of methods for oxygen radical research. CRC Press, Boca Raton, FL, pp 237\u2013241"},{"issue":"8982","key":"32_CR65","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S0140-6736(95)91747-0","volume":"346","author":"CE Mogensen","year":"1995","unstructured":"Mogensen CE, Keane WF, Bennett PH et al (1995) Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346(8982):1080\u20131084","journal-title":"Lancet"},{"key":"32_CR66","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1248\/bpb.16.970","volume":"16","author":"T Nakamura","year":"1993","unstructured":"Nakamura T, Ogawawara M, Koyama I et al (1993) The protective effect of taurine on the biomembrane against damage produced by oxygen radicals. Biol Pharm Bull 16:970\u2013972","journal-title":"Biol Pharm Bull"},{"key":"32_CR67","doi-asserted-by":"crossref","unstructured":"Nakaya N, Minami A, Harada N et al (2000) Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr 71:54\u201358","DOI":"10.1093\/ajcn\/71.1.54"},{"key":"32_CR68","first-page":"423","volume":"7","author":"H Nasri","year":"2013","unstructured":"Nasri H, Baradaran A, Ardalan MR et al (2013) Bright renoprotective properties of metformin. Beyond blood glucose regulatory effects. Iran J Kid Dis 7:423\u2013428","journal-title":"Iran J Kid Dis"},{"key":"32_CR69","doi-asserted-by":"crossref","unstructured":"Noh H, Ha H, Yu MR et al (2005) Angiotensin II mediates high glucose-induced TGF-\u03b21 and fibronectin upregulation in HPMC through reactive oxygen species. Perit Dial Int 25:38\u201347","DOI":"10.1177\/089686080502500110"},{"key":"32_CR70","doi-asserted-by":"crossref","unstructured":"Nonaka H, Tsujino T, Watari Y, Emoto N, Yokoyama M (2001) Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine: amelioration of homocysteine-induced endoplasmic reticulum stress by taurine. Circulation 104:1165\u20131170","DOI":"10.1161\/hc3601.093976"},{"key":"32_CR71","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1055\/s-2002-23101","volume":"2","author":"R Nosadini","year":"2002","unstructured":"Nosadini R (2002) Hypertension and renal complications in type 2 diabetes. Semin Vasc Med 2:109\u2013119","journal-title":"Semin Vasc Med"},{"key":"32_CR72","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1248\/cpb.41.2172","volume":"41","author":"M Ogasawara","year":"1993","unstructured":"Ogasawara M, Nakamura T, Koyama I et al (1993) Reactivity of taurine with aldehydes and its physiological role. Chem Pharm Bull (Tokyo) 41:2172\u20132175","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"32_CR73","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00726-010-0716-y","volume":"40","author":"CAM de Oliveira","year":"2011","unstructured":"de Oliveira CAM, Latorraca MQ, de Mello MAQ, Carneiro EM (2011) Mechanism of insulin secretion in malnutrition modulation by amino acids in rodent models. Amino Acids 40:1027\u20131034","journal-title":"Amino Acids"},{"key":"32_CR74","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1161\/01.CIR.0000124229.40424.80","volume":"109","author":"GY Oudit","year":"2004","unstructured":"Oudit GY, Trivieri MG, Khaper N et al (2004) Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model. Circulation 109:1877\u20131885","journal-title":"Circulation"},{"key":"32_CR75","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2337\/diabetes.49.5.735","volume":"49","author":"G Patan\u00e9","year":"2000","unstructured":"Patan\u00e9 G, Piro S, Rabuazzo AM et al (2000) Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes 49:735\u2013740","journal-title":"Diabetes"},{"key":"32_CR76","doi-asserted-by":"crossref","unstructured":"Pollare T, Lithell H, Berne C (1989) A comparison of the effects of hydro chlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321:868\u2013873","DOI":"10.1056\/NEJM198909283211305"},{"key":"32_CR77","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3109\/00365516009065404","volume":"12","author":"E Raabo","year":"1960","unstructured":"Raabo E, Terkildsen TC (1960) On the enzymatic determination of blood glucose. Scand J Clin Lab Invest 12:402\u2013407","journal-title":"Scand J Clin Lab Invest"},{"issue":"Suppl 1","key":"32_CR78","first-page":"590","volume":"62","author":"K Rett","year":"1986","unstructured":"Rett K, Jauch KW, Wicklmayr M et al (1986) Angiotensin converting enzyme inhibitors in diabetes: experimental and human experience. Postgrad Med J 62(Suppl 1):590\u2013564","journal-title":"Postgrad Med J"},{"key":"32_CR79","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/dmrr.959","volume":"25","author":"RA Ribeiro","year":"2009","unstructured":"Ribeiro RA, Bonfleur ML, Amaral AG et al (2009) Taurine supplementation enhances nutrient-induced insulin secretion in pancreatic mice islets. Diabetes Meta Res Rev 25:370\u2013379","journal-title":"Diabetes Meta Res Rev"},{"key":"32_CR80","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s11606-009-1228-x","volume":"25","author":"MA Riebel","year":"2010","unstructured":"Riebel MA, Ross C, Xu S et al (2010) Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med 25:326\u2013333","journal-title":"J Gen Intern Med"},{"key":"32_CR81","doi-asserted-by":"crossref","unstructured":"Rikimaru M, Ohsawa Y, Wolf AM et al (2012) Taurine ameliorates impaired the mitochondrial function and prevents stroke-like episodes in patients with MELAS. Intern Med 51:3351\u20133357","DOI":"10.2169\/internalmedicine.51.7529"},{"key":"32_CR82","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/j.1523-1755.2004.00925.x","volume":"66","author":"K Rossing","year":"2004","unstructured":"Rossing K, Christensen PK, Hovind P et al (2004) Progression of nephropathy in type 2 diabetic patients. Kidney Int 66:1596\u20131607","journal-title":"Kidney Int"},{"key":"32_CR83","doi-asserted-by":"crossref","unstructured":"Roysommuti S, Thaeomor A, Khimsuksri S et al (2013) Perinatal taurine imbalance alters the interplay of renin-angiotensin system and estrogen on glucose-insulin regulation in adult female rats. Adv Exp Med Biol 776:67\u201380","DOI":"10.1007\/978-1-4614-6093-0_8"},{"key":"32_CR84","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/dmrr.1302","volume":"28","author":"G Sadi","year":"2012","unstructured":"Sadi G, Eryilmaz N, T\u00fct\u00fcnc\u00fco\u011flu E, Cingir S, G\u00fcray T (2012) Changes in expression profiles of antioxidant enzymes in diabetic rat kidneys. Diabetes Metab Res Rev 28:228\u2013235","journal-title":"Diabetes Metab Res Rev"},{"key":"32_CR85","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.krcp.2014.08.001","volume":"33","author":"B Satirapoj","year":"2014","unstructured":"Satirapoj B, Adler SG (2014) Comprehensive approach to diabetic nephropathy. Kidney Res Clin Pract 33:121\u2013131","journal-title":"Kidney Res Clin Pract"},{"key":"32_CR86","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.etap.2012.08.015","volume":"34","author":"RH Sayed","year":"2012","unstructured":"Sayed RH, Salem HA, El-Sayed BM (2012) Potential protective effect of taurine against dibromoacetonitrile-induced neurotoxicity in rats. Environ Toxicol Pharmacol 34:849\u2013857","journal-title":"Environ Toxicol Pharmacol"},{"key":"32_CR87","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1016\/S0149-2918(03)90089-0","volume":"25","author":"SM Setter","year":"2003","unstructured":"Setter SM, Iltz JL, Thams J, Campbell RK (2003) Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy. Clin Ther 25:2991\u20133026","journal-title":"Clin Ther"},{"key":"32_CR88","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0149-2918(04)90125-7","volume":"26","author":"J Seufert","year":"2004","unstructured":"Seufert J, Lubben G, Dietrich K, Bates PC (2004) A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus. Clin Ther 26:805\u2013818","journal-title":"Clin Ther"},{"key":"32_CR89","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.taap.2012.03.003","volume":"260","author":"X Shao","year":"2012","unstructured":"Shao X, Hu Z, Hu C et al (2012) Taurine protects methamphetamine-induced developmental angiogenesis defect through antioxidant mechanism. Toxicol Appl Pharmacol 260:260\u2013270","journal-title":"Toxicol Appl Pharmacol"},{"key":"32_CR90","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S0272-6386(99)70037-5","volume":"34","author":"K Sharma","year":"1999","unstructured":"Sharma K, Eltayeb BO, McGowan TA et al (1999) Captopril-induced reduction of serum levels of transforming growth factor-\u03b21 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis 34:818\u2013823","journal-title":"Am J Kidney Dis"},{"key":"32_CR91","first-page":"11","volume":"9","author":"S Shrestha","year":"2008","unstructured":"Shrestha S, Gyawali P, Shrestha R et al (2008) Serum urea and creatinine in diabetic and nondiabetic subjects. J Nepal Assoc Med Lab Sci 9:11\u201312","journal-title":"J Nepal Assoc Med Lab Sci"},{"key":"32_CR92","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1081\/CEH-120027330","volume":"26","author":"RM Sindhu","year":"2004","unstructured":"Sindhu RM, Koo J-R, Roberts CK, Vaziri ND (2004) Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: response to insulin and antioxidant therapies. Clin Exp Hypertens 26:43\u201353","journal-title":"Clin Exp Hypertens"},{"key":"32_CR93","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5812\/nephropathol.9093","volume":"2","author":"M Tavafi","year":"2013","unstructured":"Tavafi M (2013) Diabetic nephropathy and antioxidants. J Nephropathol 2:20\u201327","journal-title":"J Nephropathol"},{"key":"32_CR94","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0306-3623(94)00203-Y","volume":"26","author":"JA Timbrell","year":"1995","unstructured":"Timbrell JA, Seabra V, Waterfield CJ (1995) The in vivo and in vitro protective properties of taurine. Gen Pharmacol 26:453\u2013462","journal-title":"Gen Pharmacol"},{"key":"32_CR95","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/clinchem\/25.2.336a","volume":"25","author":"A Tobacco","year":"1979","unstructured":"Tobacco A, Meiattini F, Moda E, Tarli P (1979) Simplified enzymic\/colorimetric serum urea nitrogen determination. Clin Chem 25:336\u2013337","journal-title":"Clin Chem"},{"key":"32_CR96","first-page":"352","volume":"40","author":"BD Toora","year":"2002","unstructured":"Toora BD, Rajagopal G (2002) Measurement of creatinine by Jaffe\u2019s reaction - determination of concentration of sodium hydroxide required for maximum color development in standard urine and protein free filtrate of serum. Indian J Exp Biol 40:352\u2013354","journal-title":"Indian J Exp Biol"},{"key":"32_CR97","first-page":"F429","volume":"269","author":"H Trachtman","year":"1995","unstructured":"Trachtman H, Futterweit S, Maesaka J et al (1995) Taurine ameliorates chronic streptozotocin-induced diabetic nephropathy in rats. Am J Phys 269:F429\u2013F438","journal-title":"Am J Phys"},{"key":"32_CR98","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","volume":"281","author":"RC Turner","year":"1999","unstructured":"Turner RC, Cull CA, Frighi V, Holman RR (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281:2005\u20132012","journal-title":"JAMA"},{"key":"32_CR99","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jama.1994.03510280037029","volume":"271","author":"G Viberti","year":"1994","unstructured":"Viberti G, Mogensen CE, Groop LC et al (1994) Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 271:275\u2013279","journal-title":"JAMA"},{"key":"32_CR100","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1475-2840-13-34","volume":"13","author":"I Vinagre","year":"2014","unstructured":"Vinagre I, S\u00e1nchez-Quesada JL, S\u00e1nchez-Hern\u00e1ndez JS et al (2014) Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of LDL subfraction phenotype. Cardiovasc Diabetol 13:34","journal-title":"Cardiovasc Diabetol"},{"key":"32_CR101","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/CS20110386","volume":"122","author":"B Viollet","year":"2012","unstructured":"Viollet B, Guigas B, Sanz Garcia N et al (2012) Cellular and molecular mechanisms of metformin: an overview. Clin Sci (London) 122:253\u2013270","journal-title":"Clin Sci (London)"},{"key":"32_CR102","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1076\/apab.109.1.90.4287","volume":"109","author":"BP Vohra","year":"2001","unstructured":"Vohra BP, Hui X (2001) Taurine protects against carbon tetrachloride toxicity in the cultured neurons and in vivo. Arch Physiol Biochem 109:90\u201394","journal-title":"Arch Physiol Biochem"},{"key":"32_CR103","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1080\/08860220802272563","volume":"30","author":"L Wang","year":"2008","unstructured":"Wang L, Zhang L, Yu Y et al (2008) The protective effects of taurine against early renal injury in DM-induced diabetic rats, correlated with inhibition of renal LOX-1-mediated ICAM-1 expression. Ren Fail 30:763\u2013771","journal-title":"Ren Fail"},{"key":"32_CR104","doi-asserted-by":"crossref","unstructured":"Weichselbaum TE (1946) An accurate and rapid method for the determin ation of proteins in small amounts of blood, serum and plasma. Am J Clin Pathol 10:40\u201349","DOI":"10.1093\/ajcp\/16.3_ts.40"},{"key":"32_CR105","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.2337\/diab.36.9.1014","volume":"36","author":"SA Wohaieb","year":"1987","unstructured":"Wohaieb SA, Godin DV (1987) Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat: effects of insulin treatment. Diabetes 36:1014\u20131018","journal-title":"Diabetes"},{"key":"32_CR106","doi-asserted-by":"crossref","unstructured":"Wolf G, Chen S, Ziyadeh FN (2005) From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54:1626\u20131634","DOI":"10.2337\/diabetes.54.6.1626"},{"key":"32_CR107","doi-asserted-by":"publisher","first-page":"28597","DOI":"10.1038\/srep28597","volume":"6","author":"H Xiao","year":"2016","unstructured":"Xiao H, Zhang J, Zhu Z et al (2016) Meformin is a novel suppressor for transforming growth factor (TGF)-\u03b21. Sci Rep 6:28597","journal-title":"Sci Rep"},{"key":"32_CR108","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/0006-2952(88)90259-6","volume":"37","author":"K Yamauchi-Takihara","year":"1988","unstructured":"Yamauchi-Takihara K, Azuma J, Kishimoto S et al (1988) Taurine prevention of calcium paradox-related damage in cardiac muscle. Its regulatory action on intracellular cation contents. Biochem Pharmacol 37:2651\u20132658","journal-title":"Biochem Pharmacol"},{"key":"32_CR109","doi-asserted-by":"publisher","first-page":"70","DOI":"10.14310\/horm.2002.1111039","volume":"7","author":"S Yener","year":"2008","unstructured":"Yener S, Comlecki A, Akinci B et al (2008) Serum transforming growth factor-beta 1 levels in normoalbuminuric and normotensive patients with type 2 diabetes. Effect of metformin and rosiglitazone. Hormones (Athens) 7:70\u201376","journal-title":"Hormones (Athens)"},{"key":"32_CR110","first-page":"29","volume":"9","author":"W Yin","year":"1994","unstructured":"Yin W, Seghieri G, Boni C et al (1994) Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients. Chin Med Sci J 9:29\u201333","journal-title":"Chin Med Sci J"},{"key":"32_CR111","doi-asserted-by":"crossref","unstructured":"Ziyadeh FN, Hoffman BB, Han DC et al (2000) Long -term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitrans forming factor growth factor-\u03b2 antibody in db\/db diabetic mice. Proc Natl Acad Sci U S A 97:8015\u20138020","DOI":"10.1073\/pnas.120055097"}],"container-title":["Advances in Experimental Medicine and Biology","Taurine 10"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-024-1079-2_32","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T13:16:38Z","timestamp":1709644598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-024-1079-2_32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9789402410778","9789402410792"],"references-count":111,"URL":"https:\/\/doi.org\/10.1007\/978-94-024-1079-2_32","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}